Cleared Traditional

aprevo® anterior and lateral lumbar interbody fusion device (K241332) - FDA 510(k) Clearance

Also marketed or referenced as:
aprevo® anterior lumbar interbody fusion devices with interfixation aprevo® transforaminal lumbar interbody fusion device

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241332 · Carlsmed, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
133d
Days
Class 2
Risk

K241332 is an FDA 510(k) clearance for the aprevo® anterior and lateral lumbar interbody fusion device. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Carlsmed, Inc. (Carlsbad, US). The FDA issued a Cleared decision on September 20, 2024 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Carlsmed, Inc. devices

Submission Details

510(k) Number K241332 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2024
Decision Date September 20, 2024
Days to Decision 133 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 122d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 450
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K241332.
IdentiTi™ II Interbody System
K242364 · Alphatec Spine, Inc. · Oct 2024
ARTFX Lumbar PEEK Cages
K240889 · Artfx Medical · Oct 2024
LumiVy™ Lumbar IBF System
K233807 · Vy Spine, LLC · Sep 2024
Calibrate LTX Interbody System
K242147 · Alphatec Spine, Inc. · Sep 2024
HAnano InterFuse(R) Modular Interbody
K242509 · Next Orthosurgical · Sep 2024
3D Printed PEEK Interbody System
K240250 · Nvision Biomedical Technologies, Inc. · Sep 2024